1 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Tavros Competitors or Alternatives

Tavros's top competitors include Spectrum, QUE and Genentech.

Unlock 18 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Tavros's company profile

Eoin McDonnell

Co-Founder & CEO

90/100
1 - 25
$11.5M
$100K - 5M
  • $11.5M
    $100K - 5M
  • 1 - 25
    $11.5M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $11.5M
  • $100K - 5M
View ProfileView
1
Tavros's Competitor - Spectrum logo

Thomas J. Riga

President & CEO

84/100
25 - 100
$122.5M
$5M - 25M
  • $122.5M
    $5M - 25M
  • 25 - 100
    $122.5M
  • $5M - 25M
  • 84/100
  • 25 - 100
  • $122.5M
  • $5M - 25M
View ProfileView
2
Tavros's Competitor - QUE logo

Rob Crombie

CEO

90/100
1 - 25
$16M
$5M - 25M
  • $16M
    $5M - 25M
  • 1 - 25
    $16M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $16M
  • $5M - 25M
View ProfileView
3
Tavros's Competitor - Genentech logo

Ashley Magargee

CEO

75/100
10,000 - 50,000
$2B
$10B - 50B
  • $2B
    $10B - 50B
  • 10,000 - 50,000
    $2B
  • $10B - 50B
  • 75/100
  • 10,000 - 50,000
  • $2B
  • $10B - 50B
View ProfileView
4
Tavros's Competitor - Medicenna logo

Fahar Merchant

President & CEO

90/100
16
$91.6M
$2M
  • $91.6M
    $2M
  • 16
    $91.6M
  • $2M
  • 90/100
  • 16
  • $91.6M
  • $2M
View ProfileView
5
Tavros's Competitor - Coherus logo

Dennis M. Lanfear

Chairman & CEO

40/100
330
$544.8M
$267M
  • $544.8M
    $267M
  • 330
    $544.8M
  • $267M
  • 40/100
  • 330
  • $544.8M
  • $267M
View ProfileView
Tavros' top 21 competitors are Spectrum, QUE, Genentech, Novartis, Medicenna, Coherus, Black Diamond, Gilead, Amgen, ORIC, Innate Pharma, AstraZeneca, Takeda Pharmaceutical, Pfizer, Nektar, Closing Circle, Alkermes, Merck, GSK, MorphoSys and Bristol-Myers Squibb. Together they have raised over 60.2B between their estimated 530.7K employees. Tavros's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 22B. Tavros has 16 employees and is ranked 21th among it's top 10 competitors. The top 10 competitors average 24,121.

Tavros VS Spectrum

Spectrum is Tavros's #1 competitor. Spectrum's headquarters is in Boston, Massachusetts, and was founded in 1987. Like Tavros, Spectrum also works within the Pharmaceuticals & Biotechnology sector. Spectrum generates 1,688% of Tavros's revenue.

Tavros VS QUE

QUE is one of Tavros's top rivals. QUE was founded in Melbourne, Victoria} in 2013. QUE operates in the Biotechnology industry. Compared to Tavros, QUE generates $4M more revenue.

Tavros VS Genentech

Genentech is one of Tavros's top competitors. Genentech is a Private company that was founded in 1976 in South San Francisco, California. Genentech is in the Biotechnology industry. Compared to Tavros, Genentech has 13,523 more employees.

Looking for similar companies to Tavros?

Similar Companies

Biotechnology companies in Durham

See 90 companies 
Biotechnology companies in Research Triangle

See 235 companies 
Pharmaceuticals & Biotechnology companies in Durham

See 142 companies 
Biotechnology companies in North Carolina

See 363 companies 
Pharmaceuticals & Biotechnology companies in Research Triangle

See 408 companies 
Companies in Durham with employees in 1-25 range

See 456 companies 
Pharmaceuticals & Biotechnology companies in North Carolina

See 641 companies 
Companies in Durham with revenue in $100K-5.0M range

See 1,103 companies 
Companies in Research Triangle with employees in 1-25 range

See 1,963 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Tavros and Tavros's Competitors

April 16, 2025Medthority
Sandoz files antitrust litigation against Amgen over etanercept biosimilar access....
April 16, 2025FinanzNachrichten
Innate to propose to its Annual General Meeting taking place on May 22, 2025, to move from an executive board/supervisory board corporate governance st...
April 15, 2025Powder and Bulk Solids
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....
April 15, 2025Medthority
Pfizer provides latest update on oral GLP-1 receptor agonist Danuglipron....
April 15, 2025Benzinga
Merck & Co Inc MRK and privately held Cyprumed GmbH signed a non-exclusive license and option agreement on Tuesday to develop oral formulations of Merc...
April 15, 2025Business Standard
AstraZeneca Pharma India Ltd on Tuesday said it has surrendered the marketing authorisation of prostate cancer treatment drug Olaparib (Lynparza) 100mg...
April 15, 2025Pharamceutical Technology
Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals for up to $558.4m....
April 16, 2025FinanzNachrichten
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") will hold its annual general meeting of shareholders ...
April 16, 2025BioPharma Dive
After a lengthy regulatory back-and-forth, Eisai and Biogen's Alzheimer's drug is on the market in Europe. Elsewhere, Sandoz is alleging Amgen's patent...
April 15, 2025StreetInsider
MSD obtains a Non-Exclusive License for Cyprumeds delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $4...

Frequently Asked Questions about Tavros

  1. Who are Tavros's top competitors?

    Tavros's top 3 competitors are Spectrum, QUE, Genentech.

  2. Who is similar to Tavros?

    Spectrum is the most similar to Tavros. QUE and Genentech are also similar to Tavros.

  1. Are Tavros and Spectrum competitors?

    Yes, Spectrum is one of Tavros’s top competitors.